DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Video Credit: ANI

Published on May 8, 2021 - Duration: 02:44s

DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Drugs Controller General of India (DCGI) on May 08 approved emergency use DRDO's anti-COVID drug which the agency said will be helpful in faster recovery of hospitalised patients.

While speaking to ANI, Institute of Nuclear Medicine and Allied Sciences (INMAS-DRDO) scientists spoken about drug 2-deoxy-D-glucose (2-DG).

The drug will be of immense benefit to the people suffering from COVID-19.

You are here

› Videos › COVID-19 › DCGI approves DRDO's anti-COVID drug helpful in faster recovery

💡 newsR Knowledge: Other News Mentions

COVID-19

Contagious disease caused by SARS-CoV-2

Clapping for NHS in pandemic may have been 'dangerous', health watchdog says

Clapping for the NHS in the COVID pandemic may have been "dangerous", the health service ombudsman has said.

1 week ago • Sky News

COVID still 'very much with us' with 20% of tests positive in Europe, WHO warns 01:03

Credit: euronews (in English) - Published 3 weeks ago

Bangladesh Protests: Former Indian Diplomat Blames Economic Strain, Political Opportunists 03:05

Credit: Oneindia - Published 3 weeks ago

FM Nirmala Sitharaman tables Economic Survey 2023-24 in Parliament, a day ahead of the Union Budget 15:03

Credit: Oneindia - Published on July 22, 2024

Related videos from verified sources

Covid-19: Rajnath Singh released first batch of anti-covid drug 2-DG | Oneindia News 02:34

Video credit: Oneindia - Published on May 17, 2021

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials 01:59

Video credit: ANI - Published on May 9, 2021

Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen 03:24

Video credit: HT Digital Content - Published on May 8, 2021

You might like